News releases

CEO of HungaroTrial CRO has received Scientist of Medicines Development postgraduate certification at Semmelweis University

Published on 12 February 2018

Dr. Lajos Sárosi, CEO of HungaroTrial CRO has received his postgraduate degree at Semmelweis University after successfully completing the 2 years international CEMDC program in pharmaceutical medicine.

This course consists of 8 modules covering the entire value chain of medicines development, starting from the first idea, the target identification and validation, through lead selection and optimization, preclinical and clinical testing, up to marketing authorization. The modules were organized with cooperation between different European universities, including King’s College, London and the University of Basel.

Through completion of this educational program, Dr. Sárosi became a holder of Scientist of Medicines Development Certification.

The graduation ceremony was held in the Senate room of Semmelweis University, Budapest, on the 30th of January:

http://semmelweis.hu/cemdc/about-cemdc/


Copyright: HungaroTrial 2018